CCCC icon

C4 Therapeutics
CCCC

Overview Fund Activity

114 hedge funds and large institutions have $353M invested in C4 Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 16 closing their positions.

Holders
114
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
47
Reduced
31
Closed
16
Calls
$257K
Puts
$36K
Net Calls
+$221K
Net Calls Change
-$2.03M

Top Buyers

1
State Street
1
State Street
Massachusetts
$17.2M
2
SCM
2
Soleus Capital Management
Connecticut
$12.6M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$14.4M
4
Goldman Sachs
4
Goldman Sachs
New York
$3.69M
5
WA
5
Wasatch Advisors
Utah
$52M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$26M
2
ACH
2
ArrowMark Colorado Holdings
Colorado
$44.7M
3
SFM
3
Sphera Funds Management
Israel
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
RI
5
RTW Investments
New York
$24.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
BC
126
Bridgefront Capital
Texas
– -$120K -15,925 Closed
AWS
127
AJ Wealth Strategies
New York
– -$75K -10,007 Closed
PHK
128
Point72 Hong Kong
Hong Kong
– -$24K -3,148 Closed
DFCM
129
Dark Forest Capital Management
Puerto Rico
– -$2K -303 Closed
2 3 4 5
6